News Center

Discover all of the trending news of the Ipsen Group


137 results

Group

Our pledge: summaries in plain language for all journal publ...

By Will Gattrell Today, we are broadening our commitment to providing everyone with the opportunity…

Group

Ipsen has been certified by Eurocompliance to the ISO 37001 ...

On the 15th of December 2021, Ipsen has been certified by Eurocompliance to the ISO…

Business

Statement on lanreotide in the U.S.

PARIS, FRANCE, 20 December 2021 - 6:00 PM CET - Ipsen has learned that Cipla…

Business

Ipsen continues to strengthen early oncology pipeline with Q...

Today we are pleased to announce a partnership with the Queen’s University of Belfast (QUB),…

CSR

Our pledge: industry-leading action for the climate

Today, we proudly stand together with more than 1000 companies worldwide who have pledged to…

Financial information

Strong results in Q3 as we Focus. Together. For patients �...

Today we published our third quarter financial results, which are a powerful demonstration of the…

Business

Reuters Events Pharma 2021: Transforming Medical Affairs to ...

By Steven Hildemann, MD, PhD, EVP, Chiel Medical Officer Today at Reuters Events Pharma 2021,…

Oncology

Rethinking risk factors this Liver Cancer Awareness Month

Learn how to engage with our campaign and help protect your liver health Every year,…

Event

YTD 2021 Sales announcement – Webcast details – 21 October 2...

David Loew, Chief Executive Officer, is pleased to host a conference call to discuss the…

CSR

Exceeding again our CSR-based targets

For the first time in 2019, we made a big decision: to include Environmental, Social…

Event

Ipsen – H1 Results – Conference Call – July 29, 2021

David Loew, Chief Executive Officer, is pleased to host a conference call to discuss the…

Group

A year-long partnership with the ISPC

A year-long partnership with the ISPC This year, Ipsen is partnering with the Institut…

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2022